1. Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer
   Éilis Russell et al, 2022, Cells CrossRef
2. The Effectiveness of Traditional Chinese Medicine in Treating Malignancies via Regulatory Cell Death Pathways and the Tumor Immune Microenvironment: A Review of Recent Advances
   Jingya Fu et al, 2024, The American Journal of Chinese Medicine CrossRef
3. Comprehensive Assessment of Serum hsa_circ_0070354 as a Novel Diagnostic and Predictive Biomarker in Non-small Cell Lung Cancer
   Yuejiao Huang et al, 2022, Frontiers in Genetics CrossRef
4. The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer
   Jolanta Smok-Kalwat et al, 2023, International Journal of Molecular Sciences CrossRef
5. Recent advances in immune checkpoint inhibitors for non-small lung cancer treatment
   Reem Altaf et al, 2022, Frontiers in Oncology CrossRef
6. Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer
   Xin Zhang et al, 2023, Frontiers in Pharmacology CrossRef
7. Gender Differences and Their Effects on Survival Outcomes in Lung Cancer Patients Treated With PD-1/PD-L1 Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
   S. Madala et al, 2022, Clinical Oncology CrossRef